This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 19-21, 2024
Pre-Conference Workshops on March 18, 2024Philadelphia Marriott Downtown | Philadelphia, PA

Catherine St. John
Senior Corporate Counsel, Comerical Law at Sanofi US


Catherine (Cate) St. John currently works as Senior Corporate Counsel, Commercial law at Sanofi US, providing legal counsel with respect to the sales and marketing of a blockbuster pharmaceutical drug. Prior to her current role, Cate was Vice President, FDA Regulatory and Compliance Counsel at NYC-based biotech Kadmon, which was acquired by Sanofi in 2021. Cate also spent over a decade providing expert advice to pharmaceutical clients on off label, kickback and other marketing issues at Arnold Porter Kaye Scholer. Cate is pursuing an Executive MBA at New York University (Stern).

Agenda Sessions

  • Valuable Insights into Lessons Learned for Launching Rare Disease Products